Controversy and analysis of vertebral augmentation for osteoporotic vertebral compression fracture
10.3760/cma.j.cn121113-20200813-00497
- VernacularTitle:椎体强化术治疗骨质疏松性椎体压缩性骨折的争议与分析
- Author:
Ziheng WEI
1
;
Dianwen SONG
Author Information
1. 上海交通大学附属第一人民医院骨科 201620
- From:
Chinese Journal of Orthopaedics
2020;40(20):1420-1428
- CountryChina
- Language:Chinese
-
Abstract:
Vertebral augmentation (VA) is widely used in the clinical treatment of osteoporotic vertebral compression fracture (OVCF), but its clinical efficacy has always been controversial. Since 2009, a total of four high-quality prospective randomized double-blind placebo-controlled studies have been published, but their conclusions on the effectiveness of VA were inconsistent. Latest Cochrane review (2018) and American society for bone and mineral research task report (2019) believed that compared with sham surgery, there is no advantage supporting the use of VA as a routine treatment for patients with OVCF, which triggered a new round of debates. The effectiveness of the VA remains to be determined, which makes it difficult to guide the actual clinical work of surgeons. This paper reviews the key studies in the controversy, sorts out and analyzes the details and latest views in the controversy, summarizes the impact of VA on the mortality rate of OVCF patients, and puts forward the optimal application mode of VA based on the current evidence.
